trientine has been researched along with ascorbic acid in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gregolin, C; Maiorino, M; Rigo, A; Scarpa, M; Ursini, F | 1 |
Brewer, GJ; Dick, RD; Johnson, V; Wang, Y; Yuzbasiyan-Gurkan, V | 1 |
Nagano, S; Ogawa, Y; Sakoda, S; Yanagihara, T | 1 |
Linder, MC; Malpe, R; Redekosky, C; Zerounian, NR | 1 |
Fujii, Y; Fukada, K; Nagano, S; Sakoda, S; Taniyama, M; Yamamoto, T; Yanagihara, T | 1 |
Jiskoot, W; Klem, R; Torosantucci, R; Weinbuch, D | 1 |
Hasinoff, BB; Patel, D; Wu, X; Yadav, AA | 1 |
Dong, C; Du, F; Gao, Y; Gong, X; Liu, Y; Lu, W; Shuang, S; Xian, M | 1 |
8 other study(ies) available for trientine and ascorbic acid
Article | Year |
---|---|
Formation of alpha-tocopherol radical and recycling of alpha-tocopherol by ascorbate during peroxidation of phosphatidylcholine liposomes. An electron paramagnetic resonance study.
Topics: Ascorbic Acid; Electron Spin Resonance Spectroscopy; Ferric Compounds; Glycine max; Kinetics; Liposomes; Models, Biological; Oxidation-Reduction; Peroxides; Phosphatidylcholines; Trientine; Vitamin E | 1984 |
Treatment of Wilson's disease with zinc: XI. Interaction with other anticopper agents.
Topics: Ascorbic Acid; Copper; Copper Radioisotopes; Drug Interactions; Drug Therapy, Combination; Hepatolenticular Degeneration; Humans; Penicillamine; Trientine; Zinc | 1993 |
Benefit of a combined treatment with trientine and ascorbate in familial amyotrophic lateral sclerosis model mice.
Topics: Amyotrophic Lateral Sclerosis; Animals; Ascorbic Acid; Chelating Agents; Copper; Disease Models, Animal; Gene Expression Regulation, Enzymologic; Humans; Mice; Mice, Transgenic; Superoxide Dismutase; Survival Analysis; Trientine | 1999 |
Regulation of copper absorption by copper availability in the Caco-2 cell intestinal model.
Topics: Absorption; Ascorbic Acid; Biological Transport, Active; Caco-2 Cells; Copper; Dose-Response Relationship, Drug; Humans; Intestinal Mucosa; Intestines; Trientine | 2003 |
The efficacy of trientine or ascorbate alone compared to that of the combined treatment with these two agents in familial amyotrophic lateral sclerosis model mice.
Topics: Amyotrophic Lateral Sclerosis; Animals; Antioxidants; Ascorbic Acid; Chelating Agents; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Therapy, Combination; Humans; Male; Mice; Mice, Transgenic; Superoxide Dismutase; Superoxide Dismutase-1; Survival Rate; Treatment Outcome; Trientine | 2003 |
Triethylenetetramine prevents insulin aggregation and fragmentation during copper catalyzed oxidation.
Topics: Antibodies, Monoclonal; Area Under Curve; Ascorbic Acid; Benzylamines; Catalysis; Circular Dichroism; Copper; Edetic Acid; Glutathione; Humans; Immunoglobulin G; Insulin; Light; Oxidation-Reduction; Oxygen; Recombinant Proteins; Spectrometry, Fluorescence; Temperature; Time Factors; Trientine | 2013 |
Molecular mechanisms of the biological activity of the anticancer drug elesclomol and its complexes with Cu(II), Ni(II) and Pt(II).
Topics: Antineoplastic Agents; Ascorbic Acid; Cations, Divalent; Cell Survival; Coordination Complexes; Copper; Crystallography, X-Ray; Humans; Hydrazines; K562 Cells; Kinetics; Models, Molecular; Nickel; Oxidation-Reduction; Platinum; Reactive Oxygen Species; Trientine | 2013 |
Bright-green-emissive nitrogen-doped carbon dots as a nanoprobe for bifunctional sensing, its logic gate operation and cellular imaging.
Topics: Actinidia; Ascorbic Acid; Biosensing Techniques; Carbon; Catechols; Citrus sinensis; Drinking Water; Fluorescent Dyes; Fruit; Iron; Limit of Detection; Nanostructures; Nitrogen; Oxidation-Reduction; Quantum Dots; Spectrometry, Fluorescence; Trientine; Vitis | 2018 |